Incidensen af alvorlige infektioner var 0, 03 pr. patientår hos Trudexa- behandlede patienter og 0, 03 pr. dle
au The incidence of serious infections was 0.03 per patient year in Trudexa treated patients and 0.03 per patient year in placebo and active control− treated patients.